Acadia Pharmaceuticals | Passività Correnti





Passività Correnti Cambiamento Data
Acadia Pharmaceuticals USD 356.58M 26.56M 2025-09
ALKERMES USD 474.36M 31.6M 2025-09
Alnylam Pharmaceuticals USD 1.47B 89.13M 2025-12
Biogen USD 3.35B 59.4M 2025-12
BioMarin Pharmaceutical USD 798.44M 114.19M 2025-09
Bristol-Myers Squibb USD 28.14B 608M 2025-09
Cara Therapeutics USD 10.68M 9.48M 2025-06
Corcept Therapeutics USD 172.26M 27.6M 2025-09
Cytokinetics USD 142.14M 11.08M 2025-09
Eisai JPY 387.67B 9.42B 2025-12
Eli Lilly USD 35.23B 4.91B 2025-12
Incyte USD 1.52B 176.44M 2025-12
J&J USD 54.13B 3.26B 2025-12
Moderna USD 1.99B 306M 2025-12
Neurocrine Biosciences USD 743.4M 105.4M 2025-12
Pfizer USD 36.6B 1.13B 2025-09
Prothena USD 51.44M 16.37M 2025-09
PTC Therapeutics USD 968.43M 102.18M 2025-12
Sarepta Therapeutics USD 921.42M 1.48M 2025-09
Ultragenyx Pharmaceutical USD 340.02M 46.78M 2025-09
Vanda Pharmaceuticals USD 145.16M 27.29M 2025-12
Vertex Pharmaceuticals USD 3.86B 614.1M 2025-12


Acadia Pharmaceuticals Passività Correnti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.